Indoco Remedies LimitedNSE: INDOCO

Press Release Aug 21 2024

· Issued by Indoco Remedies Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-21-2024-22

Indoco Remedies Limited has informed the Exchange regarding a press release dated August 21, 2024, titled "Indoco Remedies receives final ANDA approval from the USFDA for Lofexidine Tablets 0.18 mg with Competitive Generic Therapy designation".

View Attachment

6ix hasn’t read this filing yet.

Indoco Remedies Limited on 6ix

Earlier from Indoco Remedies

Later from Indoco Remedies

All Indoco Remedies news releases